辅助可萨诱导的皮肤不良反应的基因型和表型特征
Wimolsiri Iamsumang1, Kumutnart Chanprapaph1, Chonlaphat Sukasem2
1Division of Dermatology, Department of Internal Medicine, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.
概括
丁可引起各种皮肤反应,男性性别,艾滋病毒和长期使用会增加严重的风险. 特定的人类白细胞抗原 (HLA) 类型与不同的反应亚型相关,有助于预测严重的皮肤不良药反应 (SCAR).
科学领域:
- 药物基因组学 药物基因组学
- 皮肤病学 皮肤病学
- 免疫学 免疫学 免疫学
背景情况:
- 三醇是皮肤不良药物反应 (CADRs) 的常见原因.
- 关于这些反应的基因型和表型特征的数据有限.
- 了解这些因素对于预测和管理严重病例至关重要.
研究的目的:
- 为了研究临床特征,遗传倾向,实验室发现和治疗结果在co-trimoxazole诱导的CADRs.
- 确定与严重皮肤不良反应 (SCARs) 相关的变量.
- 探索人类白细胞抗原 (HLA) 类型和特定的CADR表型之间的联系.
主要方法:
- 对由co-trimoxazole诱导的CADR病例的医疗记录的回顾性审查 (2015年10月 - 2021年10月).
- 临床特征的评估和实验室研究.
- 重点是人类白细胞抗原 (HLA) 类I和HLA-DRB1基因定型与反应亚型相关.
主要成果:
- 包括72名患者; 72%是女性,平均年龄为38.0岁.
- 常见的反应包括斑点斑点喷发 (56.9%),DRESS (23.6%) 和史蒂文斯-约翰逊综合征 (12.5%).
- 男性性别,艾滋病毒感染,预防性和长期使用co-trimoxazole与SCARs相关. 特定的HLA基因 (例如,HLA-B*38:02,HLA-A*11:01) 与SJS,DRESS和MPE有关.
结论:
- 康特里莫克萨可以诱导各种CADR表型.
- 协同克萨诱导的SCAR的预测因素包括男性性别,艾滋病病毒,预防性/长期使用以及特定的HLA等位基因.
- 基因型和表型分析为预测严重药物反应提供了洞察力.
相关概念视频
Skin Diseases and Disorders
3.9K
Skin is the first line of defense and encounters a variety of microbes. Some pathogenic strains are often the cause of a broad range of infections of the skin and other body systems. These conditions can affect people of all ages and may have different causes, including genetic factors, infections, autoimmune reactions, environmental factors, and lifestyle choices.
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
3.9K
Allergic Drug Reactions
871
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
871
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
178
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
178
Combined Effects of Drugs: Synergism
4.0K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
4.0K
Phase I Reactions: Oxidation of Aliphatic and Aromatic Carbon-Containing Systems
215
Phase I biotransformation reactions are integral to drug metabolism, predominantly involving oxidative, reductive, and hydrolytic transformations. Chief among these are oxidative reactions, which enhance the hydrophilicity of xenobiotics and introduce polar functional groups to facilitate their elimination from the body.
Oxidation reactions are fundamental in aromatic carbon-containing systems. An example is the hydroxylation of phenobarbital, a process that transforms it into...
Oxidation reactions are fundamental in aromatic carbon-containing systems. An example is the hydroxylation of phenobarbital, a process that transforms it into...
215
Drug Metabolism: Phase II Reactions
3.9K
Phase II reactions are essential for the detoxification and elimination of drugs from the body. These reactions involve the conjugation of parent drugs or their phase I metabolites with endogenous molecules, resulting in more hydrophilic drug conjugates. The primary conjugation reactions in this phase are sulfation and glucuronidation. Both sulfation and glucuronidation typically produce biologically inactive metabolites. However, in some cases involving prodrugs, active metabolites may be...
3.9K


